General practitioners are increasingly initiating these therapies, often in response to patient demand or as part of broader cardiometabolic risk management
I've seen this with our Arizona clients managing prediabetes and metabolic syndrome
John: Hey, you know, Doc, the last show that we taped almost four years ago was so impactful
Considering the potential for therapeutic development of (in)GSH, the established safety and tolerability data, biological plausibility, and pilot level clinical evidence of benefit are further supported with this demonstration that (in)GSH is able to augment brain GSH levels
Acetyl-L-Carnitine (ALCAR): Known for brain health, ALCAR crosses the blood-brain barrier, potentially improving memory, focus, and mood
foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events